TOP1 inhibition therapy protects against SARS-CoV-2-induced lethal inflammation

請用此 Handle URI 來引用此文件： http://ir.sinica.edu.tw/handle/201000000A/83250

題名:	TOP1 inhibition therapy protects against SARS-CoV-2-induced lethal inflammation
作者:	Ho, JSY Mok, BW Campisi, L Jordan, T Yildiz, S Parameswaran, S Wayman, JA Gaudreault, NN Meekins, DA Indran, SV Morozov, I Trujillo, JD Fstkchyan, YS Rathnasinghe, R Zhu, Z Zheng, S Zhao, N White, K Ray-Jones, H Malysheva, V Thiecke, MJ Lau, SY Liu, H Zhang, AJ Lee, AC Liu, WC Jangra, S Escalera, A Aydillo, T Melo, BS Guccione, E Sebra, R Shum, E Bakker, J Kaufman, DA Moreira, AL Carossino, M Balasuriya, UBR Byun, M Albrecht, RA Schotsaert, M Garcia-Sastre, A Chanda, SK Miraldi, ER Jeyasekharan, AD TenOever, BR Spivakov, M Weirauch, MT Heinz, S Chen, H Benner, C Richt, JA Marazzi, I
公開日期:	2021
關聯:	Cell 184(10), 2618-2632.e17
URI:	http://ir.sinica.edu.tw/handle/201000000A/83250
ISSN:	http://gateway.isiknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=Drexel&SrcApp=hagerty_opac&KeyRecord=0092-8674&DestApp=JCR&RQ=IF_CAT_BOXPLOT
URL:	http://dx.doi.org/10.1016/j.cell.2021.03.051
顯示於：	生醫轉譯研究中心

顯示文件完整紀錄

checked on 2025/8/23

檢查